Logo

MTPI Statements Survey

Dear Assembly Member,

One of the most important contributions our assembly makes to the ATS, and pulmonary medicine at large, is the development of guidelines and consensus statements in the care of pulmonary disease. From the guidelines in treatment of community acquired pneumonia to statement on treatment of fungal infections, the ATS and MTPI assembly invest valuable time and effort in staying at the forefront of the field. Because keeping our statements up to date requires time and energy, we need to prioritize those that are most urgent to ATS members and the medical community at large. This is where we need your help. As we look towards ATS 2012 and beyond, the Planning Committee would like your help in determining which ATS MTPI statements are most important to you.

Sincerely,

Henry Koziel, MD
MTPI Planning Committee


Please take 5 minutes to answer the following survey and rank each statement as

1. Up to date - no need for revision
2. Still largely up to date - Revise in the next few years
3. Largely out of date – Revise now

Note: Last published year is indicated in parenthesis.
Up to date - No need for revision Still largely up to date - Revise in the next few years Largely out of date – Revise now
Emerging issues and current controversies in HIV-associated pulmonary disease (2011)
Statement on Treatment of Fungal Infection (2010)
Infections in patients receiving TNF-a antagonists *(Active project)*
Diagnosis of Fungal Infection *(No immediate plans for project)*
Diagnosis and management of Bronchiectasis: an international perspective *(Active project)*
Diagnostic standards and classification of Tuberculosis in adults and children *(Active project)*
IDSA/ATS Community Acquired Pneumonia Guidelines RECAP-Online CAP Protocol Development Wizard (2007)
Guidelines for the Management of Adults with Community-acquired Pneumonia (2001)
ATS/IDSA Statement: Diagnosis, Prevention and Treatment of Nontuberculous Mycobacterial Diseases (2007)
Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria (1997)
An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP) (2006)
Hepatotoxicity of Antituberculosis Therapy (2006)
ATS-CDC-IDSA: Controlling Tuberculosis in the United States (2005)
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia *(Active project: Update in Progress)* (2005)
ATS/CDC/IDSA Statement: Treatment of Tuberculosis ATS-CDC-IDSA Tuberculosis Treatment Guidelines for PDA (2003)
Treatment of Tuberculosis and Tuberculosis Infection in Adults & Children (1994)
Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/ CDC Recommendations-United States, 2001 (2001)
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection *(Active project: Update in Progress)* (2000)
Rapid Diagnostic Test for Tuberculosis: What is the Appropriate Use? (1997)






Online Survey Software powered by Vovici.